GRAND PHARM. GRP. HD-,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of MX6A for the last semiannual is 526.64 M EUR, and it's 24.82% lower compared to the previous semiannual. The net income of H2 23 is 98.67 M EUR.